Anthony Chibueze Nlemadim

Anthony Chibueze Nlemadim

Auto-generated profile, based on publicly available information

Anthony Chibueze Nlemadim

Department of Paediatrics, University of Calabar Teaching Hospital, Calabar, Nigeria

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2020 in Paediatrics and International Child Health
Verified
Journal Article
Closed access
ANAnthony Chibueze Nlemadim
Anthony Chibueze Nlemadim
HOHenry Chima Okpara
Henry Chima Okpara
MAMaxwell Udoh Anah
Maxwell Udoh Anah
FOFriday Akwagiobe Odey
Friday Akwagiobe Odey
MMMartin Meremikwu
Martin Meremikwu
In children with sickle cell anaemia (SCA), ischaemic electrocardiogram (ECG) changes occur during both vaso-occlusive crises (VOC) and the steady state. Myocardial ischaemia evidenced by an ischae...

5 July 2024 in hLife
Verified
Journal Article
Open access
OBOfonime E. Benjamin
Ofonime E. Benjamin
TBThelma E. Bassey
Thelma E. Bassey
CNChimaobi I. Nwagboso
Chimaobi I. Nwagboso
AOAsukwo Onukak
Asukwo Onukak
ANAnthony C. Nlemadim
Anthony C. Nlemadim
BEBASSEY EKENG
BASSEY EKENG

4 May 2021 in Hemoglobin
Verified
Journal Article
Closed access
MAMaxwell U. Anah
Maxwell U. Anah
ANAnthony C. Nlemadim
Anthony C. Nlemadim
CUChigozie I. Uzomba
Chigozie I. Uzomba
EIEgorp O. Ineji
Egorp O. Ineji
FOFriday A. Odey
Friday A. Odey
Prolonged QTc interval, a risk factor for ventricular arrhythmia, occurs in sickle cell anemia. The aim of this study was to determine the risk of prolonged QTc interval and its relationship with vaso-occlusive painful crises (VOCs) and follow-up steady-state in the same children with sickle cell anemia. This prospective cohort study enrolled 38 subjects, aged 5–17 years. History of bone pain and examination were obtained during VOC and steady-state. Assessment of QTc interval was with 12-lead electrocardiography. The QTc interval value >0.440 seconds was taken as prolonged. Median (interquartile range) of QTc interval was higher during VOC [0.447 (0.438–0.459) seconds] than during steady-state [0.435 (0.417–0.440) seconds]. Risk of prolonged QTc interval was higher during VOC (68.4%) than in steady-state (21.1%) with relative risk of 3.250 [95% confidence interval (CI) = 1.692–6.241]. Prolonged QTc interval was likely to occur [area under curve (AUC) = 0.759, p0.441 seconds. Routine electrocardiography may help to identify those with QTc intervals above this threshold for prompt cardiac-oriented management.

15 March 2024 in Pediatric Hematology Oncology Journal
Verified
Journal Article
Open access
ENElizabeth D. Nkanga
Elizabeth D. Nkanga
ANAnthony C. Nlemadim
Anthony C. Nlemadim
MAMattan Arazi
Mattan Arazi
DNDennis G. Nkanga
Dennis G. Nkanga
RDRoseline E. Duke
Roseline E. Duke
MMMartin M. Meremikwu
Martin M. Meremikwu

1 September 2023 in Nigerian Journal of Medicine
Verified
Journal Article
Open access
ANAnthony Chibueze Nlemadim
Anthony Chibueze Nlemadim
KAKingsley Onorhide Akaba
Kingsley Onorhide Akaba
IEIma-Obong Asuquo Ekanem
Ima-Obong Asuquo Ekanem
RDRoseline Ekanem Duke
Roseline Ekanem Duke
ENElizabeth Dennis Nkanga
Elizabeth Dennis Nkanga
MMMartin Madu Meremikwu
Martin Madu Meremikwu
Introduction: Cancers invade and destroy various parts of the body leading to death, if untreated. The burden of pediatric cancer is rising, especially in resource-poor regions. The aim of the study was to determine the incidence of childhood cancer types, basis of diagnosis, therapy received, and outcomes. Materials and Methods: This was a retrospective study of children aged 0-17 who were diagnosed and treated for cancer from January 2013 to December 2022. Data obtained included biodata, diagnoses, initial disease stage, diagnostic investigation results and treatments from medical records. Other outcomes assessed were relapse, abandonment of therapy, and death. Results: Of the 229 patients, males were 57.6%, 51.5% were in age-group 0-4 years and mean(SD) annual cancer crude incidence rate (CIR) was 0.29(0.09)/100,000 children. Retinoblastoma increased from 0.16/100,000 children in 2013 to 0.27/100,000 children in 2022 and had the highest average age-standardized incidence rate (0.11/100,000 children). Other malignancies had annual CIR between 0.01 and 0.08/100,000 children. The most common method of diagnosis was primary site histology (39.7%). Majority had late-stage disease (66.4%), incomplete chemotherapy (62.5%), no surgery (54.5%), and no radiotherapy (99.1%). There was disease relapse (20.5%), treatment abandonment (42.8%), discharged against medical advice (23.6%) and death (29.7%). More males than females died (1.5:1). The crude mortality rate of retinoblastoma increased from 0.01 to 0.12/100,000 children, while others fluctuated between 0.01 and 0.04/100,000 children. The average age-standardized mortality rate was highest in 0–4 years’ age group (48.5%). Conclusion: The rate of new cancers, particularly retinoblastoma, is rising in our locality. Majority present in advanced disease and are not effectively treated, resulting in increasing mortality rates. Periodic audit of childhood cancer burden may help relevant stakeholders in determining ways of curbing these worsening pediatric cancer trends.

19 December 2023 in Indian Journal of Medical and Paediatric Oncology
Verified
Journal Article
Open access
PDF file
ANAnthony Chibueze Nlemadim
Anthony Chibueze Nlemadim
TUTheophilus Ipeh Ugbem
Theophilus Ipeh Ugbem
GUGabriel Unimke Udie
Gabriel Unimke Udie
GOGodwin Cletus Omini
Godwin Cletus Omini
EIEghomwanre Davis Izekor
Eghomwanre Davis Izekor
FOFriday Akwagiobe Odey
Friday Akwagiobe Odey
Pediatric-type follicular lymphoma (PFL) is a rare, nonaggressive, slow-growing (indolent), non-Hodgkin lymphoma that is typically seen in males as a localized disease with excellent outcomes. It is largely different from follicular lymphoma (FL). Few published studies on PFL are case series in developed nations. We report on a patient with advanced PFL, a 14-year-old female with 5-year history of neck swellings, abdominal distension for a month, and pericardial effusion, among others. The swellings waxed and waned; and involved all the peripheral lymph nodes. Tuberculosis (TB) GeneXpert and human immunodeficiency virus (HIV) screening were negative. She received anti-TB drugs prior to presentation in our hospital where nodal histopathology showed effaced architecture with diffuse follicles and abundant blastoid cells as well as negative CD5 and BCL2, and positive CD10 and CD20. Diagnosis of PFL (stage 3) was made. She completed six courses of cyclophosphamide, doxorubicin, vincristine, and prednisolone and is well 9 months after therapy. The PFL usually presents with stage 1 or 2 disease unlike in the index female case that was also complicated by effusion and ascites due to late presentation. It responded to chemotherapy and has not reoccurred; in contrast to classic FL and reactive follicular hyperplasia (RFH) which should be differentiated from PFL. Although RFH can be caused by TB or HIV, they are not causes of malignant lymphadenopathy. Physicians should be aware of PFL which may present in high clinical stages, but still retain its good prognosis, for the purposes of counseling.